Carbamazepine Tablet
Product Images NDC 70518-4167

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Carbamazepine (NDC 70518-4167). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Remedy_label (Remedy Label)

Remedy_label (Remedy Label)
The label for CARBAMAZEPINE 200 mg oral tablets by RemedyRepack Inc. displays the product name, strength (200 mg), dosage form (tablet), and quantity (30 tablets). It includes storage instructions and a barcode, with additional details for repackaging and manufacturing by Bionpharma Inc., Princeton, NJ, along with warnings to keep the medication out of children's reach.*
FDA Label Image

Structure (Structure)

Structure (Structure)
Chemical structure of carbamazepine, depicting its molecular arrangement including a dibenzazepine ring system with an amide group.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.